Back

Elevated red cell distribution width (RDW) and adverse outcomes in patients with atrial fibrillation: new insights from a contemporary prospective study

1 April 2025 (10:30 - 11:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation epidemiology and clinical outcome Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Marco Vitolo

Modena Polyclinic Modena University Hospital, Modena (Italy)

5 More presentations in this session

Presentation thumbnail
Major clinical outcomes in patients with symptomatic versus asymptomatic atrial fibrillation: a Bayesian and frequentist meta-analysis
Doctor P. Karakasis (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Global, regional and national burden of atrial fibrillation and flutter attributable to metabolic risks from 1990 to 2021: analysis of data from the global burden of disease study, 2021
Doctor L. Ding (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Regional disparities in the care and outcomes of atrial fibrillation patients in a universal health care system: a population-based cohort study
Doctor M. Shurrab (Sudbury, CA)
Abstract Slides Video
Presentation thumbnail
Impact of early rhythm control in young and middle-aged patients with depression or anxiety and new-onset atrial fibrillation
Doctor S. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Impact of atrial fibrillation on cardiac arrest: a nationwide cohort study
Miss D. Rajan (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation epidemiology and clinical outcome

The Event

Event poster

EHRA 2025

1 April 2025 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Red cell distribution width and association with all-cause mortality: an easy-to-use and readily available biomarker in patients with atrial fibrillation and chronic heart failure
thumbnail
Congress Presentation
Higher red blood cell distribution width is associated with worse outcomes in patients with chronic heart failure
thumbnail
Congress Presentation
Omecamtiv mecarbil and red cell distribution width in patients with heart failure and reduced ejection fraction: results from the GALACTIC-HF trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources